Loading...
Printed on 6/29/2026
For informational purposes only. This is not medical advice.
The P/F ratio (PaO₂ divided by FiO₂) is a standard measure of oxygenation efficiency used to quantify the severity of hypoxemic respiratory failure and classify ARDS. The Berlin definition (2012) uses P/F ratio with PEEP ≥ 5 cm H₂O to classify ARDS as mild (200-300), moderate (100-200), or severe (<100). Normal P/F ratio is 400-500. The P/F ratio is one of the most commonly used parameters in ICU management for ventilator weaning decisions, prognosis assessment, and ARDS research. First determine FiO₂ with [FiO₂ Conversion Calculator](/tools/fio2-conversion), then interpret blood gas values with [ABG Interpreter](/tools/abg-interpreter). Assess overall critical illness severity with [SOFA Score](/tools/sofa-score) and [APACHE II](/tools/apache-ii) — both incorporate P/F ratio. Also calculate oxygenation deficit with [A-a Gradient Calculator](/tools/aa-gradient).
Formula: P/F Ratio = PaO₂ (mmHg) / FiO₂ (decimal). Normal ≥ 400.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
Obtain PaO₂ in mmHg from an arterial blood gas (ABG). Simultaneously document the exact FiO₂ being delivered at the time of the ABG — as a fraction (0.21 for room air to 1.0 for 100% O₂) or percentage (21–100%). For patients on supplemental oxygen, use the FiO₂ Conversion Calculator to estimate FiO₂ from flow rate. Precision matters: a 10% error in FiO₂ documentation can shift P/F ratio by 50+ points.
P/F ratio = PaO₂ (mmHg) / FiO₂ (as decimal, e.g., 0.40 for 40% O₂). Normal room air: PaO₂ ~100 mmHg / 0.21 = P/F ≈ 476. Berlin ARDS classification requires PEEP ≥5 cmH₂O: Mild ARDS = P/F 201–300 (mortality ~27%); Moderate = 101–200 (~32%); Severe = ≤100 (~45%). The PEEP requirement means ARDS cannot be diagnosed on room air or with minimal CPAP.
P/F <300 = ARDS (Berlin criteria); P/F <150 triggers consideration of prone positioning (PROSEVA trial showed 16% absolute mortality reduction); P/F <80 with optimized ventilation and PEEP = evaluate for VV-ECMO (EOLIA criteria). S/F ratio (SpO₂/FiO₂) can substitute when ABG is unavailable: S/F ~89 ≈ P/F 200 (moderate ARDS); S/F ~64 ≈ P/F 100 (severe ARDS threshold). Reassess P/F after every major ventilator change to track trajectory.
ICU Physicians & Pulmonologists
The P/F ratio is the primary oxygenation metric in the Berlin Definition of ARDS (2012). It classifies hypoxemic respiratory failure as mild (200–300), moderate (100–200), or severe (≤100) ARDS, each with distinct mortality risks and evidence-based management implications. P/F classification guides decision-making on ventilation strategy, prone positioning, neuromuscular blockade, and ECMO referral.
Hospital Medicine & ICU Teams
During COVID-19 pandemic, P/F ratio became the primary tool for classifying respiratory failure severity and guiding escalation decisions. COVID-19 ARDS may present with an 'L-type' phenotype (preserved compliance despite severe hypoxemia) — these patients may tolerate high-flow nasal cannula or awake proning before intubation, stratified by P/F severity. Serial P/F monitoring guides the window for non-invasive rescue attempts vs early intubation.
Respiratory Therapists & Intensivists
P/F ratio drives daily ventilator management decisions: tidal volume targeting (6 mL/kg IBW for ARDS), PEEP titration (higher PEEP for lower P/F), prone positioning eligibility (P/F <150), and readiness for ventilator liberation. Trend monitoring — P/F improving, stable, or declining — signals response to therapy and guides escalation vs de-escalation. SOFA score incorporates P/F as its respiratory domain.
ICU Teams
The PROSEVA trial (Guérin et al., NEJM 2013) demonstrated 16% absolute mortality reduction in prone positioning for moderate-severe ARDS with P/F <150 after lung-protective ventilation for ≥12–24 hours. P/F ratio is the primary eligibility criterion for prone positioning protocols. Target ≥16 consecutive hours prone per session. Re-evaluate P/F after return to supine to assess response.
Pulmonology & Transplant Teams
Severely impaired P/F ratio in idiopathic pulmonary fibrosis (IPF), COPD, and ARDS patients contributes to lung allocation scoring. Progressive decline in P/F over serial assessments signals accelerating disease and supports escalation of transplant evaluation urgency. P/F is one component of the Lung Allocation Score (LAS) used by UNOS for transplant prioritization.
ICU Researchers & Clinicians
Serial P/F measurements quantify the oxygenation response to specific interventions: recruitment maneuvers, PEEP changes, prone positioning sessions, inhaled nitric oxide trials, and ECMO circuit changes. A clinically meaningful improvement in P/F (typically ≥20–25 points) after an intervention confirms response and supports continuation of that intervention. P/F is the primary oxygenation endpoint in most ARDS clinical trials.
The Berlin Definition of ARDS (JAMA 2012) explicitly requires PEEP ≥5 cmH₂O to diagnose ARDS. A patient on room air or very low CPAP (2–4 cmH₂O) with P/F <300 does not meet diagnostic criteria. This requirement ensures the diagnosis applies to patients with true bilateral pulmonary infiltrates and non-cardiogenic pulmonary edema, not simply those with low PaO₂ from atelectasis or hypoventilation on no PEEP. Document the PEEP setting alongside every P/F ratio used for ARDS classification.
When ABG is unavailable (spontaneously breathing patients, resource-limited settings), the S/F ratio (SpO₂/FiO₂) is a validated proxy for P/F. S/F <89 ≈ P/F <200 (moderate ARDS; prone positioning trigger). S/F <64 ≈ P/F <100 (severe ARDS). S/F is less accurate at SpO₂ >95% due to the flat portion of the oxyhemoglobin dissociation curve. This makes S/F more useful in the 88–95% SpO₂ range where it correlates most reliably with PaO₂.
The PROSEVA trial (Guérin et al., NEJM 2013) is landmark evidence: prone positioning for ≥16 hours/session in moderate-severe ARDS (P/F <150) reduced 28-day mortality by 16% absolute (32.8% vs 16.0%). Prone positioning improves V/Q matching and recruits dependent lung units. Eligibility: ARDS with P/F <150 on PEEP ≥5 cmH₂O after at least 12–24 hours of lung-protective ventilation. Do not delay prone positioning in eligible patients.
The ARDSNet ARMA trial (NEJM 2000) demonstrated that 6 mL/kg IBW vs 12 mL/kg IBW tidal volume reduces 28-day mortality by 22% in ARDS. Low tidal volume ventilation (6 mL/kg IBW) with target plateau pressure <30 cmH₂O is standard of care for all ARDS regardless of P/F category. Even patients with P/F 200–300 (mild ARDS) benefit from lung-protective ventilation. Always calculate IBW based on height, not actual weight.
While correcting hypoxemia is essential in ARDS, hyperoxia is also harmful. A target SpO₂ of 88–95% (PaO₂ 55–80 mmHg) is appropriate for most ARDS patients. This conservative oxygenation approach (allowing permissive hypoxemia) reduces the FiO₂ and PEEP requirements needed to maintain oxygenation, potentially decreasing ventilator-induced lung injury (VILI). The ICU-ROX and HOT-ICU trials support conservative oxygenation targets.
The FACTT trial (National Heart, Lung, and Blood Institute ARDS Network, NEJM 2006) demonstrated that conservative fluid management in established ARDS (after initial resuscitation) improved oxygenation (higher P/F) and reduced ICU days compared to liberal fluid management, without increasing acute kidney injury. Once the patient is hemodynamically stable, target a negative to neutral fluid balance using diuretics, aiming for CVP <4 mmHg or PCWP <8 mmHg.
Veno-venous ECMO (VV-ECMO) is indicated for refractory ARDS when P/F <80 with FiO₂ 1.0 and optimized PEEP persists despite prone positioning, neuromuscular blockade, and high PEEP. The EOLIA trial (Combes et al., NEJM 2018) did not show mortality benefit but subsequent meta-analysis suggests benefit in the most severe cases. ECMO referral centers recommend early consultation for P/F <80 unresponsive to 6 hours of optimization. ECMO centers require P/F documentation as part of referral criteria.
Early COVID-19 ARDS often presents with severe hypoxemia (low P/F) but relatively preserved lung compliance — the 'L-type' phenotype described by Gattinoni et al. These patients may have near-normal CT lung volumes with predominantly ground-glass opacities and a relatively good response to PEEP. Awake proning is an effective non-invasive strategy for hypoxic COVID-19 patients (PRONE trial). However, the phenotype evolves over time and high PEEP may be needed as consolidation develops.
The ROSE trial (NEJM 2019) demonstrated no mortality benefit of routine neuromuscular blockade (cisatracurium) over light sedation in moderate-severe ARDS. This overturned the earlier ACURASYS trial findings. Reserve NMB for specific indications: severe patient-ventilator dyssynchrony refractory to sedation, uncontrolled driving pressure despite low TV ventilation, or prone positioning where movement control is necessary. NMB increases ICU-acquired weakness risk.
The most common calculation error is inaccurate FiO₂ documentation, especially for patients on high-flow oxygen or heated humidified high-flow (HHHFNC). On HHHFNC at 60 L/min and FiO₂ 0.60, the delivered FiO₂ is more reliable than at lower flows (where it may be diluted by room air entrainment). For mechanically ventilated patients, the ventilator display shows exact FiO₂. Always obtain the ABG simultaneously with FiO₂ documentation — a 15-minute lag with FiO₂ change invalidates the ratio.
Berlin Definition of ARDS (JAMA 2012): P/F <300 with PEEP ≥5 cmH₂O replaces 1994 AECC criteria. Prone positioning PROSEVA trial: Guérin et al. (NEJM 2013) — absolute mortality reduction 16% in P/F <150. ARDSNet ARMA: The ARDS Network (NEJM 2000) — 6 mL/kg IBW reduces 28-day mortality 22% vs 12 mL/kg. S/F ratio validation: Rice et al. (Crit Care Med 2007). EOLIA VV-ECMO trial: Combes et al. (NEJM 2018) for refractory ARDS P/F <80.
Your P/F ratio quantifies the efficiency of oxygen transfer in the lungs. A normal P/F ratio is 400–500, indicating healthy gas exchange. A P/F ratio of 300–400 suggests mild impairment in oxygenation. According to the Berlin definition of ARDS (2012), a P/F ratio of 200–300 (with PEEP >= 5 cm H2O) classifies as mild ARDS, with an estimated mortality of approximately 27%. A P/F ratio of 100–200 indicates moderate ARDS, with a mortality of approximately 32%. A P/F ratio below 100 indicates severe ARDS, with a mortality of approximately 45%.
The P/F ratio is one of the most widely used oxygenation indices in critical care. A declining P/F ratio over time suggests worsening respiratory function and may prompt escalation of ventilatory support, initiation of prone positioning (particularly for P/F < 150), or consideration of advanced rescue therapies such as ECMO for severe refractory cases.
Use the P/F ratio whenever you need to assess the severity of hypoxemic respiratory failure, particularly when evaluating a patient for ARDS or tracking their response to ventilatory interventions. It is a standard calculation in the ICU for making decisions about ventilator management, prone positioning, neuromuscular blockade, and ECMO referral.
The P/F ratio is also used as a key outcome measure in clinical trials involving ARDS therapies. It is commonly calculated at least daily (and often more frequently) in mechanically ventilated patients to guide weaning decisions. Additionally, it serves as an important communication tool when discussing patient severity with consultants or during transfer to a higher level of care.
The P/F ratio is affected by several factors beyond intrinsic lung function. Barometric pressure (altitude) influences PaO2, so the same patient may have different P/F ratios at sea level versus high altitude. The ratio does not account for the level of PEEP — a patient on high PEEP may have a significantly better P/F ratio than the same patient on low PEEP, without any change in underlying lung pathology. The Berlin criteria specify that ARDS classification requires PEEP >= 5 cm H2O.
The P/F ratio also does not incorporate PaCO2 or pH, which are important components of the overall respiratory picture. A patient with a P/F of 250 but a PaCO2 of 80 mmHg is in a very different clinical situation than one with the same P/F but a normal PaCO2. Cardiac output and mixed venous oxygen content also influence PaO2 independently of lung function. For a more complete assessment, the P/F ratio should be interpreted alongside ventilator settings, chest imaging, and overall hemodynamic status.
For related assessments, see FiO₂ Conversion, A-a Gradient and SpO₂ to PaO₂.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Convert nasal cannula L/min to FiO2% instantly. Full reference chart for 1–6 L/min, face mask, non-rebreather, and HFNC. Includes P/F ratio and A-a gradient inputs.
OpenClinicalCalculate the alveolar-arterial oxygen gradient to evaluate the cause of hypoxemia. Differentiates lung pathology from hypoventilation.
OpenClinicalEstimate PaO₂ from SpO₂ pulse oximetry using the oxygen-hemoglobin dissociation curve. SpO₂ 98%≈100 mmHg, 95%≈80, 90%≈60 (critical threshold). Useful when ABG is unavailable.
Open